Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Egypt · Delayed Price · Currency is EGP

119.00

-6.11 (-4.88%)

At close: Sep 14, 2026

Market Cap	20.08B +93.7%
Revenue (ttm)	9.88B +12.1%
Net Income	1.24B +8.3%
EPS	7.65 +6.0%
Shares Out	168.76M
PE Ratio	15.56
Forward PE	18.48
Dividend	1.50 (1.16%)
Ex-Dividend Date	Apr 28, 2026

Volume	901,466
Open	125.11
Previous Close	125.11
Day's Range	118.16 - 125.90
52-Week Range	61.01 - 178.99
Beta	0.57
Analysts	Hold
Price Target	108.20 (-9.08%)
Earnings Date	Nov 12, 2026

About EGX:PHAR

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company provides analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolics; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It exports its products. The company was incorporated in 1980 and is based in 10th of Ramadan City, Egypt. [Read more]

Industry Pharmaceutical Preparations

Founded 1980

Country Egypt

Stock Exchange Egyptian Stock Exchange

Ticker Symbol PHAR

Full Company Profile

Financial Performance

In 2025, EGX:PHAR's revenue was 9.44 billion, an increase of 24.38% compared to the previous year's 7.59 billion. Earnings were 1.44 billion, an increase of 31.57%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for PHAR stock is "Hold." The 12-month stock price target is E£108.20, which is a decrease of -9.08% from the latest price.

Price Target

E£108.20

(-9.08% downside)

Analyst Consensus: Hold

Stock Forecasts